July 3, 2022

Volume XII, Number 184

Advertisement
Advertisement

July 01, 2022

Subscribe to Latest Legal News and Analysis

June 30, 2022

Subscribe to Latest Legal News and Analysis

NAIC Continues to Refine Multiyear Work Plan to Expand Scrutiny of Holding Company Act Filings

In our report published on April 26, 2022, we discussed the New York Department of Financial Services’ (NYDFS) Circular Letter No. 5 in which it reminded the industry that acquiring less than 10% of an insurer’s voting securities does not necessarily mean that the acquirer (1) is not a “controller” and (2) does not have to submit a Form A application to the insurer’s home state or domestic regulator seeking approval for the change of control. This topic is one of several related matters that various committees, task forces and working groups of the National Association of Insurance Commissioners (NAIC) are studying and will continue to study over a multiyear period (the Project). The NAIC’s Macroprudential (E) Working Group (Working Group) is overseeing the Project. In December 2021, when the NAIC’s Financial Stability (E) Task Force and the Working Group developed a “List of [13] Regulatory Considerations – PE Related and Other” (List), we reported on that development. We now report on the Working Group’s publication of regulators’ reactions to the List. (The Working Group will accept comments on the regulators’ reactions until June 13, 2022.)

IN DEPTH


INTRODUCTION

The NAIC and the Working Group have continuously stressed that while many of the issues in the List arise in the context of Form A filings submitted by private equity funds (PE Funds) and subsequent related holding company act filings, the issues can also be spotted in other contexts. That said, some of the issues that seem of most concern to regulators are associated with services provided to insurers by fellow PE Fund portfolio companies, investments structured by such companies or debt obligations issued by portfolio companies. One of the regulatory considerations listed back in December 2021 was whether to define “private equity funds,” however, regulators have now decided (at least for the moment) that a definition is not needed. In any case, regulators are concerned with all owners and controllers of insurers, not just PE Funds. Anyone interested in Holding Company Act matters should pay attention to the Working Group, the progress of the Project and the inputs it will receive from a wide variety of regulators here and abroad in the coming years.

We lead off with regulator reactions to Form A filing considerations. These reactions, in the form of possible “stipulations” or conditions to Form A approvals, will provide a good indication of the direction in which regulators may be headed. However, the remaining sections of this article highlight the concerns that regulators have been expressing in recent NAIC meetings, both with respect to Form A filings and to other Holding Company Act disclosure requirements, including:

  • Corporate developments that current Holding Company Act filing requirements do not capture

  • Influence and activities of less than 10% shareholders, particularly vis-à-vis investment management agreements

  • Identify and understand complex, structured securities and their features

  • Use of “offshore reinsurance”

  • Whether (and when) explicit capital support for an insurer’s balance sheet is needed and from whom it can be obtained.

FORM A CHANGE OF CONTROL FILINGS

The Working Group’s latest report begins with a variety of “stipulations” that regulators have suggested could be used in connection with Form A change of control application approvals, with some of the stipulations or conditions being time limited.

Limited Duration Stipulations

  • Requiring risk-based capital (RBC) levels to be maintained more than company action/trend test levels

  • Requiring RBC reports quarterly rather than annually

  • Prohibiting dividends, even ordinary dividends

  • Requiring applicants to provide capital maintenance support, possibly in a funded trust account

  • Requiring insurers to disclose “material changes” (with accompanying financial projections) in items, such as operations, dividends, investments, affiliated agreements (particularly cost-sharing agreements) and reinsurance that would otherwise not be reportable or subject to prior approval or non-disapproval under existing Holding Company Act laws.

Continuing Stipulations

  • Prior approval is required for all material reinsurance agreements, even those with non-affiliates

  • Early notification (within 30 days) of all changes in directors and executive officers (including the filing of biographical affidavits)

  • Sharing all disclosure documents provided to prospective investors or to lenders involved with the acquisition of the insurer in question

  • Disclose all involved parties. Those with voting equity or with any economic interest in intermediate companies/entities are up to the ultimate controller to disclose

  • Require all of the above parties to supply financial statements.

REFERRALS TO OTHER NAIC WORKING GROUPS

As mentioned above, there are a number of NAIC committees, task forces and working groups that are contributing to the review of the 13 regulatory considerations, with some of the other bodies having already begun their work. Below are the issues being referred to each group.

Group Solvency Issues (E) Working Group

  • Develop an optimal disclosure protocol that covers otherwise unaddressed solvency concerns (e.g., drilling deeper into the motivations/purposes of the acquirer, understanding the acquirer’s expected sources of returns or profits, inquiring into the acquirer’s ability to provide capital support)

  • Train regulators in states that may not have a high volume of Form A applications to review

  • Identify sources of expertise for regulators in all states to utilize as needed (with applicants footing the bill for such assignments) concerning “complex transaction, especially to understand non-U.S. affiliations and when assessing multiple complex Form A applications”

  • Focus on persons/entities that do not have 10% or more ownership of voting securities, including:

    • Non-customary minority shareholder rights

    • Investment management agreement provisions, such as costly termination provisions or excessive control over investment decisions

  • Gather “detailed examples to address the complexity and creativity involved” in Form A applications

  • Consider ways to “better target…pertinent agreements to assess…” the impact of less than 10% owners

  • Consider enhanced Form B (annual holding company group registration) filings.

Risk-Focused Surveillance (E) Working Group

  • Work on affiliate agreements and Form D (material transactions with affiliates) filings (which the group is already doing)

  • Focus on investment management agreement termination provisions on subadvisors (as well as any additional fees)

  • Create protocols to identify and evaluate securities/investments developed by affiliates of controllers or affiliates of a PE Fund’s portfolio companies, with respect to conflicts of interest and hidden or excessive fees

  • Evaluate whether to involve the NAIC’s Valuation of Securities (E) Task Force

  • Examine surplus notes, particularly those with floating interest rates; possibly liaison with the NAIC’s Statutory Accounting Principles (E) Working Group

  • Make capital support agreements stronger and focus on ensuring that such agreements are executed with proper parties, particularly for life and annuity issues where liabilities are long term

  • Consider PE Fund acquirers (and others) that may have little or limited experience in operating insurers, as well as possible overreliance on third-party service providers and:

    • More Form A disclosures

    • Compare with EU practices

    • Consider providing more guidance to financial examiners.

Both the Statutory Accounting Principles (E) Working Group and the Risk-Focused Surveillance (E) Working Group

  • Develop codes to identify and facilitate the disclosure of related-party investments, particularly structured securities (e.g., collateralized loan obligations (CLOs)) where a related party may have originated one or more of the obligations included in the CLO held by the insurer

  • For CLOs, contemplate another referral—to the NAIC’s Examination Oversight (E) Task Force—to ascertain ways and means to obtain more detail about CLO investments, including obtaining copies of disclosures provided to potential investors

  • With respect to structured securities in general—whether issued or structured by related parties or not—the Working Group will draw upon expertise provided by the NAIC’s Capital Markets Bureau and its Securities Valuation Office to increase monitoring/analytic capabilities, including the use of rating agency reports to study potential credit, complexity and illiquidity risks as well as lack of transparency. Additionally, regulators plan to study:

    • Adequacy of insurer governance and controls with respect to investing and monitoring investments in complex securities

    • Improvement of regulatory tools and insurer disclosures (pursuant to a project to revamp Schedule D) to “automate” screening for investments in complex securities

    • Reliance on rating agency ratings, monitoring over the next several years as the project continues.

DISCLAIMERS OF AFFILIATION

The Working Group noted the NYDFS’ Circular Letter No. 5 and confirmed that copies had been sent to all members of the Working Group. The Working Group is particularly interested in disclaimers filed by entities that manage assets/investments. Regulators will use the information contained in the new-for-2021 Schedule Y, Part 3 to identify any disclaiming person/entity holding 10% or more of an insurer’s voting securities and will pursue ways and means to identify persons/entities of interest that hold less than 10% of an insurer’s voting securities.

“OFFSHORE REINSURERS”

Members of the Working Group have made known that they do not understand why insurers turn to offshore reinsurers, captives and sidecar entities. They plan to meet with industry participants and offshore regulators to understand the drivers and to answer the following questions:

  • Do US regulatory requirements mean that insurers are holding “excess reserves”?

  • Are there other drivers?

PENSION RISK TRANSFERS

The Working Group will be consulting with the US Department of Labor and working with a number of other bodies within the NAIC, including the Life Actuarial (A) Task Force, Statutory Accounting Principles (E) Working Group and the Life Risk-Based Capital (E) Working Group, to (1) better understand the role that more complex investments play in these large transactions, (2) evaluate the application of Life Actuarial (A) Task Force’s already exposed Actuarial Guideline to pension risk transfers and (3) study whether better disclosures regarding pension risk transfers are required. The Working Group will also continue to follow the work of the Longevity Risk Transfer subgroup of the Life Risk-Based Capital (E) Working Group.

© 2022 McDermott Will & EmeryNational Law Review, Volume XII, Number 126
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Andrea Best Insurance Regulatory Compliance Attorney McDermott Will Emery Law Firm UK
Partner

Andrea T. Best* advises clients on insurance regulatory compliance throughout the United States. She works with insurers, reinsurers, intermediaries, brokers, trade associations and others in the insurance market.

Andrea actively monitors state insurance-related legislative and regulatory developments and works extensively with London, Bermuda and European insurance market participants regarding non-admitted insurance and reinsurance transactions in the United States, including regulatory advice on structuring insurtech, and on sharing economy and gig economy insurance programs in...

+44 20 7577 6950
Dan Brown Insurance Attorney McDermott Will & Emery San Francisco, CA
Partner

Dan Brown represents insurance companies, start-ups, agents, brokers and other stakeholders in all aspects of the admitted, exempt and surplus lines insurance markets in the United States.

Dan advises alien or foreign insurers on how to comply with various state laws in placing business; early-stage and developed insurtech entities on regulatory and corporate issues; insureds on exempt and specialty lines; producers on licensing, placement and premium tax issues, including digitization of the process; and insureds on coverage and placement issues. He advises London market...

628-218-3820
H. Michael Byrne Insurance Lawyer McDermott Will & Emery Law Firm
Partner

H. Michael (Mike) Byrne has extensive experience in complex insurance transactions, regulation and InsurTech matters. He advises US and international insurers and reinsurers, investors, producers and technology companies on a broad range of matters, including obtaining regulatory approvals for M&A, change of control and affiliate transactions; forming, licensing and structuring business operations; drafting and negotiating agreements; M&A involving producers and service providers; and developing and obtaining approvals for unique products. He delivers practical and business-focused...

1 212 547 5388
Thomas M. Dawson Corporate & Insurance Attorney McDermott Will & Emery New York, NY
Partner

Thomas M. Dawson represents US and non-US insurers on regulatory, licensing and corporate matters.

Tom advises industry participants on a wide variety of regulatory and transactional matters, including cybersecurity compliance, insurtech ventures and Holding Company Act filings. He has helped clients form, acquire and invest in US insurers, reinsurers and intermediaries. He counsels non-insurers on advertising, licensing and marketing generally, and provides regulatory compliance advice to service contract issuers and other specialty product providers.

Tom has guided non-US...

212-547-5419
Michael R. Halsband Insurance Attorney McDermott Law Firm New York
Partner

Michael R. Halsband has more than 25 years of leadership experience in the insurance and reinsurance industry, including in investment banking and capital markets. He is the global leader of the Firm’s Insurance Transactions and Regulation Group.

His wide-ranging experience includes insurance broker and carrier M&A, new company formation, capital raises and new product development (principally for InsurTech startups); complex structured (re)insurance transactions; insurance-linked securities (ILS); distressed portfolio run-off administration...

212-547-5401
Advertisement
Advertisement
Advertisement